AstraZeneca PLC (AZN)

7,180.00
-45.00(-0.62%)
  • Volume:
    51,057
  • Bid/Ask:
    846.30/846.50
  • Day's Range:
    7,149.60 - 7,209.00

AZN Overview

Prev. Close
7,225
Day's Range
7,149.6 - 7,209
Revenue
19.47B
Open
7,161.8
52 wk Range
6,736 - 10,120
EPS
1.77
Volume
51,057
Market Cap
93.88B
Dividend (Yield)
216.00 (2.96%)
Average Vol. (3m)
2,456,037
P/E Ratio
40.69
Beta
0.43
1-Year Change
1.46%
Shares Outstanding
1,312,738,153
Next Earnings Date
Apr 30, 2021
What is your sentiment on AstraZeneca PLC?
or
Vote to see community's results!

AstraZeneca PLC News

AstraZeneca PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellNeutral
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellSell

AstraZeneca PLC Company Profile

AstraZeneca PLC Company Profile

Employees
76100

AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). It has approximately 38 projects in Phase I, including 26 new molecular entities (NMEs), and 12 oncology combination projects. It has approximately 43 projects in Phase II, including 25 NMEs; six additional indications for projects that have reached phase II, and 12 oncology combination projects. It has approximately 22 projects in late-stage development, either in Phase III/pivotal Phase II studies or under regulatory review.

Read More
  • Above 7500 to 9750 soon these weeks bullish sentiments business development infrastructure expenditures stimulus package cause its stance growth economics of scales
    0
    • may be buy or sell the stock but be very cautious before being vaccinated : some serious cases in Europe especially with young to intermediate people
      8
      • blabla bla  are u scientist? or just repeating hear?
        0
      • Jenny GoughIm not anti vaccine at all. Ill take the pfizer moderna and even the sputnik asap. The fact is that the european health autority has recommended not to use the astra for people under 55. My message is informative, yours is insulting.
        1
      • GP GAPYes Im chief nurse teacher in a very big hospital. Not specialised in vaccine but i know a little bit about heath. And im a pro vaccine. But the rule we were givenby health autorities  was : Astra not for people under 55.
        1
    • This is moving now....at last! US approval coming.
      1
      • The cause behind the suspected vaccine side effects has been found. This is the opinion of a Norwegian expert group that examined the three healthcare employees who were admitted to hospital after being vaccinated with Astra Zeneca's vaccine. The vaccine triggered a strong immune reaction in the people. - I see no other reason than that it is the vaccine that triggers it, says the chief physician and professor Pål Andre Holme to VG. Sell off coming
        5
        • I guess that puts this Professor at odds with all the others looking at the data then.   Strange they were all healthcare employees.
          0
        • u shorting?
          0
      • AZN will go up & up
        2
        • Up today due to the £700m+ from disposal; vaccine is fine - EU politics.   Also good for those on kidney dialysis like a member of my family who can have this vaccine (& who has no ill effects). Only not for profit as long as pandemic is declared as one - but everyone likely to need annual jabs after that... great company.
          0
          • buy guys world health organization is giving advice to buy astrazeneca , you guys dum enough?
            2
            • Don't buyyyyyyy!!!!!
              6
              • Ive had the vaccine. It was great): All mainstream drug companies suffering as hospitals taken over with covid and thus everything else delayed and postponed.  Backlog will have to be caught up...  Also AZ only free for duration of pandemic... wont always be a pandemic but will likely need annual vaccines...  Hold but forget about it for a bit.
                7
                • So much good news today why it is going down oO
                  1
                  • What a *****stock! So disappointing!
                    0
                • Good info about vaccine acceptancy
                  0
                  • It looks like purchasing volume are getting interesting....
                    0
                    • 11/02 earnings before market.
                      0
                      • how much possible drop after?
                        0
                    • good for long term
                      0
                      • Ruin that trash, because of that trash whole markate crashing.
                        4
                        • Naked Brand stock 🚀
                          2
                          • it has started to roll :)
                            1
                            • finaly
                              0
                          • 8.000-8.100£
                            1
                            • if it goes above 7,600, Ciao
                              2
                              • sure, but when?
                                1
                              • sorry, I mean: yes, it woill go above, and NO, I definitely won't sell it at 7,6000. This is value stock. It should go way higher. It's only a matter of time.
                                1
                              • Anton Todorov ciao, I mean its going up (breaks resistance)
                                0
                            • what is the forecast for AZ share?
                              4
                              • AZ will cover India👍🏻
                                1
                                • it is on its way to Brazil too. hopefully the stocks will go up.
                                  0
                              • COVID-19 vaccine should have no significant positive impact on share price as AZN is selling the vaccine without profit, just covering costs. It's an attempt to serve the world during the pandemic.
                                0
                                • AZN free only for UK
                                  1
                                • Val Lange sadly, no: "AstraZeneca continues to engage with governments, multilateral organisations and collaborators around the world to ensure broad and equitable access to the vaccine at no profit for the duration of the pandemic." source: AstraZeneca press release of  30 December 2020 07:00 GMT
                                  1
                                • ...but it's good PR  and long-term strategy
                                  0
                              • AZN got the approval in UK. I wonder why it shows strong sell still
                                1
                                • Yucel Kr  stock price showing small gain but no Tesla effect despite the practacality of the vaccine as it can be kept in fridge unlike pfizer which  needs artic conditions!!
                                  0
                                • if it does the same as pfizer, biontech & moderna then will go down tomorrow
                                  0
                                • They are selling the vaccine without profit, just covering costs. Company decision to serve the world this way.
                                  0
                              • In couple of days time, India is sure to issue EUA for AZN. They are not waiting for UK regulator sign-off.
                                0
                                • Malaysia doubled vaccine order from AZ, why the stock is not responding?
                                  1
                                  • malaysia is buying at cost. wont do much for astra's bottomline
                                    0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.